This combination PDT therapy enhanced the number of activated tumor-specific CD8+ T lymphocytes in tumor-draining lymph nodes, which was associated with a reduction in tumor spread potential (e.g., in colon26- HA and 4T1 breast carcinomas). The gene discussed is CD8A; the disease is breast carcinoma.